While a positive trend for plasma oxytocin measurements was observed when participants were taking SB-121, we note that there are significant limitations to plasma oxytocin measurements.
← all excerpts
Results of a phase Ib study of SB-121, an investigational probiotic formulation, a randomized controlled trial in participants with autism spectrum disorder.
1
—
—